介入性肿瘤学市场规模、份额、成长分析（按产品类型、按手术类型、按癌症类型、按最终用户、按地区）- 产业预测 2025-2032

预计 2023 年全球介入性肿瘤学市场规模将达到 27.5 亿美元，并从 2024 年的 30 亿美元成长到 2032 年的 60.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.1%。

介入性肿瘤学是癌症治疗领域中一个新兴且快速发展的领域，它利用微创技术和先进的影像引导技术（如 CT、超音波、MRI 和 X 光）来诊断和治疗癌症。这种创新方法可以使用切片穿刺针、消融电极和血管内导管等专门仪器精确瞄准肿瘤，即使在难以到达的位置。介入性肿瘤学与手术和放射等传统治疗方法相结合，提供有针对性的治疗，旨在缓解癌症症状，同时减少侵入性手术的需要。此外，介入性肿瘤科医师擅长进行内视镜检查和大肠镜检查，以治疗各种癌症，包括肝癌、肾癌、肺癌、乳癌、摄护腺癌和转移性肿瘤，最终改善患者的治疗效果。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局

介入性肿瘤学市场规模（依产品类型和复合年增长率）（2025-2032）

• 市场概览
• 消融设备
  • 射频消融设备
  • 微波消融装置
  • 冷冻消融装置
  • 不可逆电穿孔装置
  • 高强度聚焦超音波（HIFU）系统
• 栓塞装置
  • 放射栓塞装置（Y-90微球）
  • 经动脉栓塞化疗（TACE）药物
  • 药物释放型珠（DEB）
  • 非药物释放型珠
• 支援的设备
  • 微导管
  • 导管导引线
  • 针刺（切片检查、消融）
  • 导管鞘套和鞘套
  • 影像造影显影剂
• 其他的
  • 机器人辅助系统
  • 规划导航软体平台

介入性肿瘤学市场规模（依手术类型和复合年增长率） (2025-2032)

• 市场概览
• 热烧蚀
• 非热消融
• 栓塞治疗
• 椎体成形术和骨水泥成形术
• 切片检查和肿瘤标记程序

介入性肿瘤学市场规模（依癌症类型和复合年增长率）（2025-2032）

• 市场概览
• 肝癌
• 肺癌
• 肾癌
• 骨转移
• 乳癌
• 摄护腺癌
• 胰臟癌
• 大肠直肠癌
• 其他的

介入性肿瘤学市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院
• 门诊手术中心（ASC）
• 癌症研究中心
• 介入放射科诊所

介入性肿瘤学市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Boston Scientific Corporation-USA
• Medtronic plc-Ireland
• Siemens Healthineers-Germany
• Terumo Corporation-Japan
• Becton, Dickinson and Company（BD）-USA
• Merit Medical Systems-USA
• AngioDynamics, Inc.-USA
• ALPINION MEDICAL SYSTEMS-South Korea
• ATRICURE, INC.-USA
• EndoShape, Inc.-USA
• ABK Biomedical Inc.-Canada
• Cook Medical Inc.-USA
• Sirtex Medical Limited-Australia
• BTG International Ltd.-UK
• Hologic, Inc.-USA
• Canon Medical Systems Corporation-Japan
• GE Healthcare-USA
• Philips Healthcare-Netherlands

结论和建议

Global Interventional Oncology Market size was valued at USD 2.75 billion in 2023 and is poised to grow from USD 3.0 billion in 2024 to USD 6.02 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

Interventional oncology is an emerging and rapidly growing field in cancer care, leveraging minimally invasive techniques and advanced image guidance technologies, such as CT, ultrasound, MRI, and X-rays, to diagnose and treat cancer. This innovative approach allows for precise targeting of tumors, even in difficult-to-reach areas, using specialized instruments like biopsy needles, ablation electrodes, and intravascular catheters. As a key component alongside traditional therapies such as surgery and radiation, interventional oncology provides focused treatments that aim to reduce the need for invasive procedures while alleviating cancer symptoms. Additionally, interventional oncologists are skilled in conducting endoscopies and colonoscopies, addressing various cancers, including liver, kidney, lung, breast, prostate, and metastatic tumors, ultimately improving patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Interventional Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Interventional Oncology Market Segments Analysis

Global Interventional Oncology Market is segmented on the basis of product, cancer type, procedure, end user, and region. By product, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. By Cancer Type, the market is segmented into Liver Cancer, Kidney Cancer, Breast Cancer, Lung Cancer, Bone Cancer, Prostate Cancer, and Other Cancers. By procedure, the market is segmented into Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy (TARE/SIRT), Transcatheter Arterial Chemoembolization (TACE), Thermal Tumor Ablation, and Transcatheter Arterial Embolization/Bland Embolization (TAE). By end-user, the market is segmented into hospitals, ambulatory surgery centers, and research & academic institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Interventional Oncology Market

The rising global incidence of cancer serves as a major catalyst for the interventional oncology market. As the population ages and lifestyle-related risk factors contribute to higher cancer rates, there is an increasing need for effective treatments. This growing demand encourages healthcare providers to implement cutting-edge interventional techniques that not only improve patient outcomes but also enhance survival rates. Consequently, the market is witnessing significant innovation and expansion driven by the urgent requirement for advanced cancer care solutions tailored to meet the needs of patients worldwide. This momentum is likely to continue as the challenge of cancer persists.

Restraints in the Global Interventional Oncology Market

A significant challenge facing the Global Interventional Oncology market is the limited awareness and training regarding interventional oncology techniques among healthcare professionals. Many practitioners lack familiarity with the newest innovations and procedures, which can result in their underutilization. This gap in knowledge can hinder the market's growth potential. Furthermore, the necessity for specialized training may impede the swift adoption of advanced technologies across different healthcare environments. As healthcare providers navigate these challenges, the overall progress in integrating interventional oncology practices may be delayed, ultimately affecting the market's expansion and evolution in an increasingly competitive landscape.

Market Trends of the Global Interventional Oncology Market

The Global Interventional Oncology market is witnessing a profound shift towards minimally invasive techniques, propelled by the dual benefits of reduced recovery times and minimized complications for patients. This trend is gaining traction as both patients and healthcare professionals increasingly prefer these innovative methods, which are designed to improve treatment outcomes. Furthermore, advancements in technology, such as enhanced imaging modalities and precision-guided interventions, are being rapidly integrated into clinical practice, thus elevating the efficacy and safety of oncological procedures. This evolution not only reflects a broader movement towards patient-centered care but also positions minimally invasive interventional oncology as a key growth driver in the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Interventional Oncology Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Ablation Devices
  • Radiofrequency (RF) Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Irreversible Electroporation Devices
  • High-Intensity Focused Ultrasound (HIFU) Systems
• Embolization Devices
  • Radioembolization Devices (Y-90 Microspheres)
  • Transarterial Chemoembolization (TACE) Agents
  • Drug-Eluting Beads (DEBs)
  • Non-drug-eluting Beads
• Support Devices
  • Microcatheters
  • Guidewires
  • Needles (biopsy, ablation)
  • Introducers and Sheaths
  • Imaging Contrast Agents
• Others
  • Robotic Assistance Systems
  • Software Platforms for Planning and Navigation

Global Interventional Oncology Market Size by Procedure Type & CAGR (2025-2032)

• Market Overview
• Thermal Ablation
• Non-thermal Ablation
• Embolization Procedures
• Vertebroplasty & Cementoplasty
• Biopsy and Tumor Marking Procedures

Global Interventional Oncology Market Size by Cancer Type & CAGR (2025-2032)

• Market Overview
• Liver Cancer
• Lung Cancer
• Kidney Cancer
• Bone Metastases
• Breast Cancer
• Prostate Cancer
• Pancreatic Cancer
• Colorectal Cancer
• Others

Global Interventional Oncology Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Cancer Research Centers
• Interventional Radiology Clinics

Global Interventional Oncology Market Size & CAGR (2025-2032)

• North America (Product Type, Procedure Type, Cancer Type, End User)
  • US
  • Canada
• Europe (Product Type, Procedure Type, Cancer Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Procedure Type, Cancer Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Procedure Type, Cancer Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Procedure Type, Cancer Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boston Scientific Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc - Ireland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALPINION MEDICAL SYSTEMS - South Korea
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ATRICURE, INC. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EndoShape, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABK Biomedical Inc. - Canada
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sirtex Medical Limited - Australia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTG International Ltd. - UK
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare - Netherlands
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations